[FATE] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -18.82%
YoY- -19.46%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 2,515 2,802 2,429 2,817 2,632 1,661 1,026 81.70%
PBT -33,520 -28,302 -26,609 -23,478 -19,760 -16,027 -16,782 58.53%
Tax 0 691 910 1,015 1,091 817 339 -
NP -33,520 -28,302 -26,609 -23,478 -19,760 -16,027 -16,782 58.53%
Tax Rate - - - - - - - -
Total Cost 36,035 31,104 29,038 26,295 22,392 17,688 17,808 59.91%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -1,332.80 -1,010.06 -1,095.47 -833.44 -750.76 -964.90 -1,635.67 -12.74%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -0.44 -0.37 -0.40 -0.36 -0.30 -0.25 -0.31 26.27%
EPS Diluted -0.44 -0.37 -0.40 -0.36 -0.30 -0.25 -0.31 26.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.